Latest Trimedyne Inc. Stories
Reportlinker.com announces that a new market research report related to the Medical devices industry is available in its catalogue.
TRIMEDYNE, INC. (OTCBB: TMED) today announced its financial results for the quarter and nine months ended June 30, 2008. Revenues for the quarter were $1,385,000, an increase of 16% from revenues of $1,197,000 for the prior year's quarter.
TRIMEDYNE, INC. (OTCBB: TMED) today announced it has entered into a Letter of Intent with FemSuite, LLC, a privately held company based in San Francisco which develops, manufactures and markets a variety of devices for use in the gynecology field.